Terms: = Colorectal cancer AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2 AND Prognosis
3 results:
1. NR4A1 depletion inhibits colorectal cancer progression by promoting necroptosis via the RIG-I-like receptor pathway.
Zhu J; Li J; Yang K; Chen Y; Wang J; He Y; Shen K; Wang K; Shi T; Chen W
Cancer Lett; 2024 Mar; 585():216693. PubMed ID: 38301909
[TBL] [Abstract] [Full Text] [Related]
2. ddx3 acts as a tumor suppressor in colorectal cancer as loss of ddx3 in advanced cancer promotes tumor progression by activating the MAPK pathway.
Shen L; Zhang J; Xu M; Zheng Y; Wang M; Yang S; Qin B; Li S; Dong L; Dai F
Int J Biol Sci; 2022; 18(10):3918-3933. PubMed ID: 35844798
[No Abstract] [Full Text] [Related]
3. ddx3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract] [Full Text] [Related]
